Skip to content

Current Status of Primary Malignant Melanoma of Uterus and Ovary in Japan, Retrospective Analysis (KCOG-G1701s)

Current Status of Primary Malignant Melanoma of Uterus and Ovary in Japan, Retrospective Analysis (KCOG-G1701s) - KCOG-G1701s

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000030553
Enrollment
40
Registered
2017-12-25
Start date
2017-08-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Malignant Melanoma of Uterus and Ovary

Interventions

None listed

Sponsors

Kansai Clinical Oncology Group (KCOG)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients who received treatment for primary uterine and ovarian malignant melanoma during the 20-year period from April 1997 through March 2017

Exclusion criteria

Exclusion criteria: Metastatic uterine and ovarian malignant melanoma

Design outcomes

Primary

MeasureTime frame
Prognostic Factors in primary malignant melanoma of uterus and ovary

Countries

Japan

Contacts

Public ContactMitsutake Yano

Saitama Medical University International Medical Center Department of Pathology

yano1210@oita-u.ac.jp042-984-0609

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026